Intervertebral Disc Degenerative Disorder clinical trials in California
18 active Intervertebral Disc Degenerative Disorder trials with a site in California. Describe your situation to see which ones look like a fit.
- HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
- Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
- Investigation of DEXA-C Anterior Cervical Interbody System
- Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
- A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
- Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
- OssDsign® Spine Registry Study ("Propel")
- OssiMend BA in Posterolateral Instrumented Lumbar Fusion
- Comparison of Artificial Disc Implants in Cervical Disc Arthroplasty
- Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure
- Brain Mechanisms Supporting Cannabis-induced Pain Relief
- Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions
- Cervical Interbody Implant Study
- Lumbar Interbody Implant Study
- Posterior Cervical Fixation Study
- A Clinical Registry of Orthobiologics Procedures
- Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
- Non-surgical Spinal Decompression Therapy and Outcomes
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.